Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer
Status:
Terminated
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate if treatment with zalutumumab in combination with
chemotherapy and radiotherapy (chemo-radiation) will lead to a prolonged life in patients
with lung cancer compared to patients treated with chemo-radiation alone.